Moderna, Inc. — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2021-03-15

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	M	10000	$20.93	Acquired	10000	Direct
2021-03-15	Common Stock	M	34	$14.22	Acquired	10034	Direct
2021-03-15	Common Stock	S	411	$136.00	Disposed	9623	Direct
2021-03-15	Common Stock	S	801	$137.00	Disposed	8822	Direct
2021-03-15	Common Stock	S	602	$138.26	Disposed	8220	Direct
2021-03-15	Common Stock	S	300	$139.09	Disposed	7920	Direct
2021-03-15	Common Stock	S	1874	$140.38	Disposed	6046	Direct
2021-03-15	Common Stock	S	2988	$141.31	Disposed	3058	Direct
2021-03-15	Common Stock	S	2101	$142.17	Disposed	957	Direct
2021-03-15	Common Stock	S	957	$143.09	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$20.93	M	10000	Disposed	2029-03-08	Common Stock (10000)	Direct
2021-03-15	Stock Option (Right to Buy)	$14.22	M	34	Disposed	2028-02-28	Common Stock (34)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.47 to $136.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.61 to $137.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.71 to $138.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.78 to $139.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.81 to $140.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.82 to $141.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.85 to $142.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.87 to $143.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F10: 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in 12 equal quarterly installments thereafter.

F11: 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.